Metabolism of the prostaglandins and thromboxanes. 1980

J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011457 Prostaglandins D Physiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation, and have potential antithrombotic effects. PGD
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
January 1978, Recent progress in hormone research,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
July 1978, The Medical journal of Australia,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
January 1978, Progress in medicinal chemistry,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
January 1978, Annual review of biochemistry,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
April 1984, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
January 1981, Bulletin europeen de physiopathologie respiratoire,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
January 1981, Annual review of pharmacology and toxicology,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
November 1978, Ugeskrift for laeger,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
April 1979, British journal of haematology,
J A Oates, and L J Roberts, and B J Sweetman, and R L Maas, and J F Gerkens, and D F Taber
January 1978, Advances in prostaglandin and thromboxane research,
Copied contents to your clipboard!